Immunogen Inc (DELISTED) (IMGN:DL)
31.23
0.00 (0.00%)
USD |
NASDAQ |
Feb 13, 16:00
Immunogen Gross Profit (Quarterly): 111.27M for Sept. 30, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 111.27M |
June 30, 2023 | 82.24M |
March 31, 2023 | 49.24M |
December 31, 2022 | 40.99M |
September 30, 2022 | 15.38M |
June 30, 2022 | 14.16M |
March 31, 2022 | 38.08M |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 |
Date | Value |
---|---|
June 30, 2017 | |
March 31, 2017 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 | 2.536M |
June 30, 2011 | |
March 31, 2011 | 5.211M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
14.16M
Minimum
Jun 2022
111.27M
Maximum
Sep 2023
50.19M
Average
40.99M
Median
Dec 2022
Gross Profit (Quarterly) Benchmarks
AbbVie Inc | 8.216B |
Pfizer Inc | 11.50B |
Johnson & Johnson | 14.87B |
Merck & Co Inc | 12.24B |
Cerevel Therapeutics Holdings Inc | -- |